Aurora Cannabis NYSE: ACB
Aurora Cannabis Inc. produces and distributes medical cannabis products.
Name | Aurora Cannabis |
Ticker | ACB |
Exchange | NYSE |
Sector | Health Care |
Industry | Cannabis Specialties |
Price
52W Low/High |
7.79
3.83 / 18.92 |
Momentum | Sharp Down |
Market cap | 1.0 B |
1Y Total Return |
-2.90%
Weak |
1Y Volatility |
141.96%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Aurora Cannabis Inc. produces and distributes medical cannabis products.
Details
Ticker | ACB |
Name | Aurora Cannabis |
ISIN | |
CUSIP | |
Exchange | NYSE |
Sector | Health Care |
Industry | Cannabis Specialties |
Country | Canada |
Currency | U.S. Dollar |
Share as of 4/15/21
Close Price | 7.79 |
52W Low/High | 3.83 / 18.92 |
Market cap | 1.0 B |
1Y Total Return |
-2.90%
Weak |
1Y Volatility |
141.96%
High Risk |
Beta | 2.52 |
PE (trailing) | - |
12M Dividends | - |
Last Dividend Date | - |
Dividend Yield | - |
Fin. Strength
Net Profit Margin | -857.6% |
Cash from Op. / Cur. Liabilities | -1.88 |
Diluted Earnings / Share | -17.81 |
ROE | - |
ROIC | -72.5% |
Price / Revenue | - |
Price / Book | - |
Price / CF | - |
Current Ratio | 5.0 |
Cur.Liabilities / Tot.Liabilities | 0.2 |
Financial Leverage | 0.22 |
in Mils USD |
rolling-year up to December
|
||||
---|---|---|---|---|---|
Income Statement | 2020 | 2019 | 2018 | 2017 | |
Revenue |
222
|
222
|
88
|
-
|
|
Gross Profit |
-
|
122
|
51
|
-
|
|
R&D |
14
|
17
|
5
|
-
|
|
EBITDA |
-1,827
|
-1,009
|
-5
|
-
|
|
Operating Income |
-301
|
-250
|
-200
|
-
|
|
Net Income exc. Extra |
-
|
-
|
-
|
-
|
|
per Share | |||||
Diluted avg Shares |
-
|
-
|
-
|
-
|
|
EPS exc. Extra |
-17.81
|
-12.20
|
0.00
|
-
|
|
Dividend |
-
|
-
|
-
|
-
|
|
Div. Yield (an.) |
-
|
-
|
-
|
-
|
|
Balance Sheet | 2020 | 2019 | 2018 | 2017 | |
Total Assets |
2,220
|
3,566
|
3,612
|
-
|
|
Cash, Eq & Invt ShortTerm |
347
|
182
|
154
|
-
|
|
Total Current Assets |
582
|
481
|
292
|
-
|
|
Total Non-Current Assets |
1,637
|
3,086
|
3,320
|
-
|
|
Intangibles |
1,032
|
2,224
|
2,774
|
-
|
|
Total Liabilities |
496
|
647
|
427
|
-
|
|
Total Current Liabilities |
118
|
163
|
88
|
-
|
|
Long Term Debt |
379
|
484
|
338
|
-
|
|
Shareholder equity |
1,723
|
2,934
|
3,180
|
-
|
|
Cash Flow | 2020 | 2019 | 2018 | 2017 | |
Cash from Operations |
-220
|
-221
|
-152
|
-
|
|
Depreciation |
79
|
82
|
39
|
-
|
|
Cash from Investing |
-87
|
-327
|
-351
|
-
|
|
Capex |
110
|
378
|
173
|
-
|
|
Cash from Financing |
490
|
627
|
280
|
-
|
|
Stock Issued |
587
|
261
|
-40
|
-
|
|
Debt (LT) Issued |
-91
|
380
|
359
|
-
|
|
Free Cash Flow |
-1,873
|
-1,875
|
-
|
-
|
|
Ratios | 2020 | 2019 | 2018 | 2017 | |
Net Profit Margin |
-
|
-
|
-
|
-
|
|
NCFO / Op.Income |
-
|
-
|
-
|
-
|
|
Current Ratio |
5.0
|
2.9
|
3.3
|
-
|
|
Financial Leverage D/E |
0.22
|
0.16
|
0.08
|
-
|
|
Return on Capital Avg |
-72.5%
|
-44.7%
|
-2.6%
|
-
|
|
Return on Shareholder Equity |
-
|
-
|
-
|
-
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available